Sort   by:  
 Page size 
UnknownSerial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.
Not available
S-EPMC2677798 | biostudies-literature
UnknownRegional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.
Not available
S-EPMC12260115 | biostudies-literature
UnknownAmyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.
Not available
S-EPMC9828339 | biostudies-literature
UnknownA trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Not available
S-EPMC8988051 | biostudies-literature
UnknownSafety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial.
Not available
S-EPMC11838922 | biostudies-literature
UnknownAmyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer's Disease.
Not available
S-EPMC7415608 | biostudies-literature
Sort   by:  
 Page size